INSPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Inspire Medical Systems, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$70.15+1.36 (+1.98%)
Close on Oct 19, 2026
- Market cap
- $2.03B
- P/E (TTM)
- 15.2
- Dividend yield
- –
Share price
−$7.86 (−10.08%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Inspire Medical Systems, Inc. grew revenue 4.3% to $898.74M over the twelve months to Jun 30, 2026. Operating income rose 30.7% to $54.12M, moving the operating margin from 4.8% to 6.0%. Free cash flow was $117.09M, up 37.7% from a year earlier.
Revenue
$898.74M
+4.3% vs. a year earlier
Operating income
$54.12M
+30.7% vs. a year earlier
Free cash flow
$117.09M
+37.7% vs. a year earlier
EPS, diluted
$4.62
+165.5% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.03B
- P/E ratio
- 15.2
- Price to sales
- 2.26
- Price to book
- 2.46
- Dividend yield
- –
- Free cash flow yield
- 5.77%
Fundamentals
- Revenue
- $898.74M
- Net income
- $135.04M
- EPS, diluted
- $4.62
- Free cash flow
- $117.09M
- Book value per share
- $28.53
- Diluted shares
- 29M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Revenue
$898.74M+4.3% YoY
Gross profit
$774.11M+6.4% YoY
Operating income
$54.12M+30.7% YoY
Net income
$135.04M+154.2% YoY
EPS, diluted
$4.62+165.5% YoY
Free cash flow
$117.09M+37.7% YoY
Reported periodTrailing twelve months